International Journal of Molecular Sciences, 2025 Comparative Assessment of Acute Pulmonary Effects Induced by Heat-Not-Burn Tobacco Aerosol Inhalation in a Murine Model Kim B., Yang W., Seong Y. et al. Olink Target 96 MouseEnvironmental Health & ToxicologyPathophysiologyMouse Plasma | | | | |
Frontiers in Immunology, 2025 Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis Ozuna H., Bojja D., Partida-Sanchez S. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2025 Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial Pakola S., Clubb J., Kudling T. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Scientific Reports, 2025 Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics Liu Y., Zhang Y., Wan Q. Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma | | | | |
The FASEB Journal, 2025 Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis Hu Z., Chen S., Zhang E. et al. Olink Target 96CVDNeurologyPatient StratificationPlasma | | | | |
Nature Genetics, 2025 Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease Yoshiji S., Lu T., Butler-Laporte G. et al. Olink Explore 3072/384Metabolic DiseasesCVDCross-platform ValidationPlasma | | | | |
CHEST Critical Care, 2025 Immunomodulation for acute respiratory distress syndrome: insights from proteomics in COVID-19 Rademaker E., Haitsma Mulier J., Drylewicz J. et al. Olink Target 96Respiratory DiseasesInfectious DiseasesImmunotherapyPathophysiologyPlasma | | | | |
Pediatric Research, 2025 Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls Buonsenso D., Cotugno N., Amodio D. et al. Olink Target 96Infectious DiseasesPediatricsPatient StratificationPlasma | | | | |
British Journal of Dermatology, 2025 Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS) Silverberg J., Eichenfield L., Blauvelt A. et al. Olink Target 96Dermatological DiseasesPathophysiologyTape Strips | | | | |
European Heart Journal, 2025 Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia Baragetti A., Alieva A., Grigore L. et al. Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma | | | | |
European Heart Journal, 2025 Mosaic loss of Y chromosome and mortality after coronary angiography Weyrich M., Zewinger S., Sarakpi T. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Journal of Translational Medicine, 2025 Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis Guo H., Gao J., Gong L. et al. Olink Explore 3072/384Dermatological DiseasesPathophysiologyPlasma | | | | |
European Journal of Preventive Cardiology, 2025 Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence Li J., Lai Y., Jiang C. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Biomolecules, 2025 A Genetic and Environmental Analysis of Inflammatory Factors in Chronic Widespread Pain Using the TwinsUK Cohort Cherny S., Livshits G., Williams F. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Hepatology International, 2025 Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data Wang H., Xu X., Shi L. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma | | | | |
European Journal of Heart Failure, 2025 Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study Monzo L., Xhaard C., Ferreira J. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025 Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation Guo X., Shi W., Lu J. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Clinical Proteomics, 2025 ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach Wu T., Hsiao T., Chen C. et al. Olink Explore 3072/384OncologyPatient StratificationBone Marrow Plasma | | | | |
American Journal of Physiology-Heart and Circulatory Physiology, 2025 Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis Goñi-Olóriz M., Garaikoetxea Zubillaga M., San Ildefonso-García S. et al. Olink Target 96CVDMetabolic DiseasesPathophysiologyTissue Lysate | | | | |
Cell, 2025 Systems-level immunomonitoring in children with solid tumors to enable precision medicine Chen Q., Zhao B., Tan Z. et al. Olink Target 96OncologyPediatricsPatient StratificationPlasma | | | | |